These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 33309846

  • 1. Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract.
    Dos Santos AM, Meneguin AB, Akhter DT, Fletcher N, Houston ZH, Bell C, Thurecht KJ, Gremião MPD.
    Eur J Pharm Biopharm; 2021 Jan; 158():371-378. PubMed ID: 33309846
    [Abstract] [Full Text] [Related]

  • 2. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
    Ma Y, Fuchs AV, Boase NR, Rolfe BE, Coombes AG, Thurecht KJ.
    Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
    [Abstract] [Full Text] [Related]

  • 3. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L, Yang H, Lou Y, Wu JY, Miao J, Lu XY, Gao JQ.
    Int J Pharm; 2019 Feb 25; 557():170-177. PubMed ID: 30597264
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F, Zhang M, Gao Y, Zhu S, Chen S, Liu W, Zhong H, Liu J.
    Drug Deliv; 2016 Jul 25; 23(6):2003-14. PubMed ID: 26181840
    [Abstract] [Full Text] [Related]

  • 7. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 25; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel.
    Ren T, Gou J, Sun W, Tao X, Tan X, Wang P, Zhang Y, He H, Yin T, Tang X.
    Mol Pharm; 2018 Jul 02; 15(7):2870-2882. PubMed ID: 29863879
    [Abstract] [Full Text] [Related]

  • 10. Statistical simplex centroid experimental design for evaluation of pectin, modified chitosan and modified starch as encapsulating agents on the development of vitamin E-loaded microparticles by spray-drying.
    Ribeiro AM, Gonçalves A, Rocha F, Estevinho BN.
    Int J Biol Macromol; 2024 Jun 02; 269(Pt 1):131792. PubMed ID: 38677704
    [Abstract] [Full Text] [Related]

  • 11. Retrograded starch/pectin coated gellan gum-microparticles for oral administration of insulin: A technological platform for protection against enzymatic degradation and improvement of intestinal permeability.
    Meneguin AB, Beyssac E, Garrait G, Hsein H, Cury BSF.
    Eur J Pharm Biopharm; 2018 Feb 02; 123():84-94. PubMed ID: 29175551
    [Abstract] [Full Text] [Related]

  • 12. Taurine loaded chitosan-pectin nanoparticle shows curative effect against acetic acid-induced colitis in rats.
    Ahmed O, Abdel-Halim M, Farid A, Elamir A.
    Chem Biol Interact; 2022 Jan 05; 351():109715. PubMed ID: 34695389
    [Abstract] [Full Text] [Related]

  • 13. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 14. Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone.
    Gadalla HH, Soliman GM, Mohammed FA, El-Sayed AM.
    Drug Deliv; 2016 Sep 01; 23(7):2541-2554. PubMed ID: 25853478
    [Abstract] [Full Text] [Related]

  • 15. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles.
    Ling K, Wu H, Neish AS, Champion JA.
    J Control Release; 2019 Feb 10; 295():174-186. PubMed ID: 30557649
    [Abstract] [Full Text] [Related]

  • 16. Cyclodextrin nanoparticle bound oral camptothecin for colorectal cancer: Formulation development and optimization.
    Ünal S, Aktaş Y, Benito JM, Bilensoy E.
    Int J Pharm; 2020 Jun 30; 584():119468. PubMed ID: 32470483
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
    Alkhader E, Roberts CJ, Rosli R, Yuen KH, Seow EK, Lee YZ, Billa N.
    J Biomater Sci Polym Ed; 2018 Dec 30; 29(18):2281-2298. PubMed ID: 30376409
    [Abstract] [Full Text] [Related]

  • 18. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L, Dong H, Dong A, Zhang J.
    Eur J Pharm Biopharm; 2015 Nov 30; 97(Pt A):107-17. PubMed ID: 26515259
    [Abstract] [Full Text] [Related]

  • 19. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
    Maciel VBV, Yoshida CMP, Pereira SMSS, Goycoolea FM, Franco TT.
    Molecules; 2017 Oct 12; 22(10):. PubMed ID: 29023400
    [Abstract] [Full Text] [Related]

  • 20. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.
    Song Q, Jia J, Niu X, Zheng C, Zhao H, Sun L, Zhang H, Wang L, Zhang Z, Zhang Y.
    Nanoscale; 2019 Aug 29; 11(34):15958-15970. PubMed ID: 31418432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.